Xerava 100 mg/1
eravacycline · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Tetraphase Pharmaceuticals, Inc.
Xerava is a injection, powder, lyophilized, for solution containing eravacycline at 100 mg/1, taken intravenous. Manufactured by Tetraphase Pharmaceuticals, Inc..
Key Facts
- Brand Name
- Xerava
- Generic Name
- eravacycline
- NDC Code (Product)
71773-100- Manufacturer
- Tetraphase Pharmaceuticals, Inc.
- Strength
- 100 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- NDA211109
- Marketing Start
- 09/10/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Xerava used for?
Xerava contains eravacycline. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Xerava a controlled substance?
Xerava is not classified as a controlled substance by the DEA.
What is the generic name for Xerava?
The generic name for Xerava is eravacycline. There are no other listed brand versions of eravacycline.
What is the NDC code for Xerava 100 mg/1?
The NDC (National Drug Code) for Xerava 100 mg/1 is 71773-100, listed by Tetraphase Pharmaceuticals, Inc..
Other Xerava Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)